Table 3.
Barriers to clinical trial
Mistrust in the Medical And Scientific Community |
Safely and Efficacy of Procedure or Medicati on |
Fear of Experimentation or Randomization |
Limited understanding/access to info about clinical trials |
Time Commitment and/or location concerns |
Patient- Researcher Relationship |
Financial burden (i.e. inadequate insurance, no compensati on, lack of research funding) |
Caregiving Duties |
Inadequate Transport |
Limited understanding of the informed consent process |
Reputation of Medical Professional or Facility |
Work Commitment |
Unequa l Treatment |
Religious Beliefs |
Physical Discomfort |
Lack of Interest |
Unexpected Event (e.g., illness, incarnation, or oversleeping |
|||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Author/Year | Sample Size | Sex | |||||||||||||||||
Baquet, C. et al., 2006 | 561 | Female | x | x | |||||||||||||||
BeLue, R et al., 2006 | 35 | Female | x | x | x | ||||||||||||||
32 | Male | x | x | x | x | x | |||||||||||||
Brewer, L. et al., 2014 | 381 | Female | x | ||||||||||||||||
Brooks, M.M. et al., 2009 | 29 | Female | x | x | x | x | x | x | x | x | |||||||||
Brown, D. et al., 2000 | x | x | x | ||||||||||||||||
Study 1 | 64 | Female | |||||||||||||||||
Brown, D. et al., 2000 | x | x | x | ||||||||||||||||
Study 2 | 61 | Female | |||||||||||||||||
Farmer, D. et al., 2007 | 61 | Female | x | x | x | x | x | x | x | x | x | ||||||||
Frierson, G. et al., 2019 | 57 | Female | x | x | x | x | x | x | x | ||||||||||
Haynes-Maslow, L. et al., 2014 | 82 | Female | x | x | x | x | x | x | |||||||||||
Lang, R. et al., 2013 | 69 | Female | x | x | x | x | |||||||||||||
35 | Male | x | x | ||||||||||||||||
Linden, H. et al., 2007 | 58 | Female | x | x | x | x | x | x | x | x | x | x | |||||||
Martin, A et al., 2013 | 36 | Female | x | x | x | ||||||||||||||
Newman, P. et al., 2006 | 8 | Female | x | ||||||||||||||||
Owens, O. et al., 2013 | 43 | Female | x | x | x | x | x | x | x | x | |||||||||
38 | Male | x | x | x | x | x | x | x | x | ||||||||||
Rivers, D. et al., 2019 | 42 | Female | x | x | x | x | x | x | |||||||||||
Smith, Y. et al., 2007 | 31 | Female | x | x | x | x | x | x | x | ||||||||||
Trauth, J. et al., 2005 | 299 | Female | x | x | x | x | x | x | |||||||||||
Unson, C. et al., 2001 | 16 | Female | x | x | x | x | x | x | |||||||||||
Voytek, C. et al., 2011 | 17 | Female | x | x | x | x | x | x | x | x | x |
NOTE: This table lists each study included in the systematic review and whether the specific barrier to participation in clinical trials was identified by the study’s male and/or female subjects.